Results 261 to 270 of about 104,266 (306)
Some of the next articles are maybe not open access.
Clinics in Liver Disease, 2006
Drug-induced liver injury is a common but underdiagnosed cause of liver disease with an incidence that is rapidly increasing. The authors address some of the more controversial aspects in relation to drug-induced liver injury: recommendations on the use of anti-tuberculosis therapy in the presence of underlying cirrhosis, the role of periodic liver ...
Rahul A, Nathwani, Neil, Kaplowitz
openaire +2 more sources
Drug-induced liver injury is a common but underdiagnosed cause of liver disease with an incidence that is rapidly increasing. The authors address some of the more controversial aspects in relation to drug-induced liver injury: recommendations on the use of anti-tuberculosis therapy in the presence of underlying cirrhosis, the role of periodic liver ...
Rahul A, Nathwani, Neil, Kaplowitz
openaire +2 more sources
Drug Intelligence & Clinical Pharmacy, 1985
An adolescent male with chronic schizophrenic disorder, paranoid type, was treated with molindone. He developed hepatotoxicity in the early treatment phase as evidenced by flu-like symptoms and laboratory abnormalities of liver functions. These symptoms and his hepatic functions improved on discontinuing molindone.
S C, Bhatia, L E, Banta, D W, Ehrlich
openaire +2 more sources
An adolescent male with chronic schizophrenic disorder, paranoid type, was treated with molindone. He developed hepatotoxicity in the early treatment phase as evidenced by flu-like symptoms and laboratory abnormalities of liver functions. These symptoms and his hepatic functions improved on discontinuing molindone.
S C, Bhatia, L E, Banta, D W, Ehrlich
openaire +2 more sources
Hepatotoxicity of the thiazolidinediones
Clinics in Liver Disease, 2003Troglitazone, the first of the thiazolidinediones, caused severe hepatotoxicity including liver failure in several patients. It appears, however, that the thiazolidinediones as a class are not as hepatotoxic as troglitazone. Comparative data at comparable dates of usage indicate that pioglitazone and rosiglitazone are not significant hepatotoxins. This
Keith G, Tolman, Jane, Chandramouli
openaire +2 more sources
Hepatotoxicity of Antidepressants
International Clinical Psychopharmacology, 1991Detection of abnormal liver function tests in a patient receiving an antidepressant or other psychopharmacological agent presents a major problem to the clinician, who must decide whether or not to withdraw a drug which may be of central importance in the patient's management.
openaire +2 more sources
Hepatotoxicity of Chemotherapy
Seminars in Oncology, 2006The selection of an antineoplastic regimen for an oncology patient is based first on the availability of effective drugs and then on a balancing of potential treatment-related toxicities with the patient's clinical condition and associated comorbidities. Liver function abnormalities are commonly observed in this patient population and identifying their
Justin, Floyd +3 more
openaire +2 more sources
Clinical Pharmacokinetics, 2014
In a recent article, Scheen [1] reviews the hepatic safety of incretin-based medications. The author concluded that ‘‘no hepatotoxicity has been reported in the development programme of alogliptin,’’ citing a review article from 2010, the year of alogliptin’s first approval (in Japan) [2].
Elizabeth, Barbehenn +3 more
openaire +2 more sources
In a recent article, Scheen [1] reviews the hepatic safety of incretin-based medications. The author concluded that ‘‘no hepatotoxicity has been reported in the development programme of alogliptin,’’ citing a review article from 2010, the year of alogliptin’s first approval (in Japan) [2].
Elizabeth, Barbehenn +3 more
openaire +2 more sources
Clinics in Liver Disease, 2007
There is appropriate concern about the potential risk for hepatotoxicity from herbal products because they are unregulated and therefore not standardized with regard to their contents. This is particularly the case for the crude herbals that are commonly formulated as a mixture, so that their ingredients may be ambiguous and even contain harmful ...
openaire +2 more sources
There is appropriate concern about the potential risk for hepatotoxicity from herbal products because they are unregulated and therefore not standardized with regard to their contents. This is particularly the case for the crude herbals that are commonly formulated as a mixture, so that their ingredients may be ambiguous and even contain harmful ...
openaire +2 more sources
Acta Medica Scandinavica, 1986
ABSTRACT.Amiodarone has proved very effective in the treatment of otherwise resistant cardiac tachyarrhythmias. The use of amiodarone has, however, been limited due to its serious side‐effects. A patient with cholestatic hepatitis due to amiodarone treatment is presented below and a review of the hepatotoxicity of amiodarone is given.
openaire +2 more sources
ABSTRACT.Amiodarone has proved very effective in the treatment of otherwise resistant cardiac tachyarrhythmias. The use of amiodarone has, however, been limited due to its serious side‐effects. A patient with cholestatic hepatitis due to amiodarone treatment is presented below and a review of the hepatotoxicity of amiodarone is given.
openaire +2 more sources
Seminars in Liver Disease, 2002
Herbal hepatotoxicity is increasingly recognized as herbal medicines become more popular in industrialized societies. Some herbal products may potentially benefit people with liver disease; however, these benefits remain generally unproved in humans, and a greater awareness of potential adverse effects is required.
openaire +2 more sources
Herbal hepatotoxicity is increasingly recognized as herbal medicines become more popular in industrialized societies. Some herbal products may potentially benefit people with liver disease; however, these benefits remain generally unproved in humans, and a greater awareness of potential adverse effects is required.
openaire +2 more sources